TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF)(the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that it will present at the OTCQB Venture Virtual Investor Conference on August 7th, 2025.
Master clinical evaluation for medical software in our comprehensive course. Learn practical application for AI/ML devices, data generation, and regulatory differences. Enhance compliance, safety, and performance. Join for certification and CPD points. Perfect for developers and manufacturers.
Master clinical evaluation for medical software in our comprehensive course. Learn practical application for AI/ML devices, data generation, and regulatory differences. Enhance compliance, safety, and performance. Join for certification and CPD points. Perfect for developers and manufacturers.
Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets
Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets